aliqopa
Pharmaranks rates Aliqopa 3.4/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Aliqopa (Copanlisib Dihydrochloride) is a medication supplied as a powder.
Copanlisib Dihydrochloride · by Bayer Pharms
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Copanlisib Dihydrochloride
- Form
- Powder
- Strength
- Copanlisib Dihydrochloride 60MG/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Bayer Pharms
- FDA application
- NDA209936
- Availability
- Discontinued (per FDA)
Dosage forms
Powder
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Aliqopa rated?
- pharmaranks gives Aliqopa a composite score of 3.4 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Aliqopa?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Aliqopa. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Aliqopa?
- Aliqopa is marketed by Bayer Pharms. You can see Bayer Pharms's full profile, rating, and other products on pharmaranks.
- Is Aliqopa a brand-name or generic drug?
- Aliqopa is a brand-name product with the active ingredient Copanlisib Dihydrochloride.
- Is Aliqopa available over the counter?
- No. Aliqopa is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Aliqopa come in?
- Aliqopa is currently marketed as powder, per the FDA's National Drug Code Directory.
- Is Aliqopa FDA-registered?
- Aliqopa is on record with the U.S. FDA under application number NDA209936. You can verify this on its official FDA label.
- Has Aliqopa been recalled by the FDA?
- Aliqopa has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Aliqopa safe?
- There's no single safe-or-not verdict. pharmaranks gives Aliqopa a recall-safety score of 68/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
abiraterone acetate
Abiraterone Acetate
acular
Ketorolac Tromethamine
acular ls
Ketorolac Tromethamine
aimovig
Erenumab-Aooe
albendazole
Albendazole
alphagan p
Brimonidine Tartrate
Compare Aliqopa head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
aliqopa
68/100